Emcitate Tablet, For Suspension
Product Images NDC 87216-0100

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Emcitate (NDC 87216-0100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rare Thyroid Therapeutics International Ab, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Emc00 0002 01)

Chemical structure diagram of tiratricol, the active ingredient in EMCITATE 350 mcg tablets for suspension. The diagram shows the molecular arrangement including iodine atoms and hydroxyl groups relevant to its chemical composition.*

FDA Label Image

Figure (Emc00 0002 02)

An instructional diagram showing a scored tablet labeled with the number 3 and letter E. The diagram illustrates splitting one whole tablet into two half tablets, each half retaining either the 3 or E marking.*

FDA Label Image

Figure (Emc00 0002 03)

An instructional diagram showing components for oral administration: a clean drinking glass with room temperature water, an oral syringe labeled with graduation marks and parts (tip, barrel, plunger, cap), an enteral feeding tube with a matching syringe, and a blade with a pill cutter device.*

FDA Label Image

Figure (Emc00 0002 04)

An illustration of a glass with a liquid inside, depicting a visual related to the preparation or administration of a drug suspension, likely for oral use.*

FDA Label Image

Figure (Emc00 0002 05)

Drug Facts panels for EMCITATE tiratricol 350 micrograms tablets for suspension. The image shows multiple text blocks likely containing usage, warnings, and ingredient details for the prescription oral tablet product by Rare Thyroid Therapeutics International AB.*

FDA Label Image

Figure (Emc00 0002 06)

An instructional diagram showing a close-up of a finger peeling back a corner of a label or sticker to reveal adhesive side with small printed text. The image focuses on the peeling action and the detailed corner area of the label, without additional text or branding visible.*

FDA Label Image

Figure (Emc00 0002 07)

An illustration showing fingers holding and preparing to fold or break a tablet, likely demonstrating how to handle the tablet for suspension preparation. The image focuses on the tablet placement between the fingers.*

FDA Label Image

Figure (Emc00 0002 08)

An instructional illustration showing a close-up of two hands separating the tops of two small containers or ampoules, suggesting the action of opening or breaking them apart.*

FDA Label Image

Figure (Emc00 0002 09)

An instructional illustration showing a hand opening a blister pack of tablets from a folded plastic case. The tablet is partially visible inside the blister, designed for oral suspension preparation. The image demonstrates how to access the tablet within the packaging.*

FDA Label Image

Figure (Emc00 0002 10)

An instructional illustration showing a syringe being prepared for use, with one hand holding the syringe and the other hand removing the cap from the needle. An arrow indicates the direction of removing the cap.*

FDA Label Image

Figure (Emc00 0002 11)

An instructional illustration showing a person using a dropper to withdraw liquid from a vial or bottle. One hand holds the vial steady while the other hand pulls the dropper upward to extract the liquid, indicating the correct technique for drawing medication into the dropper for oral administration.*

FDA Label Image

Figure (Emc00 0002 12)

A black-and-white instructional illustration showing a hand squeezing a tablet from a container into a suspension vessel, indicated by a downward arrow pointing into the vessel. The image demonstrates the preparation step for a tablet for suspension.*

FDA Label Image

Figure (Emc00 0002 13)

An instructional illustration showing a person using both hands to depress a plunger in a syringe or dropper device, indicating liquid extraction or dispensing. The image highlights proper hand positioning and downward motion for operating the device.*

FDA Label Image

Figure (Emc00 0002 14)

An instructional diagram showing the use of a syringe to measure 10 mL of liquid from a container. The image highlights the 10 mL mark on the syringe and depicts a hand drawing liquid into the syringe, emphasizing correct measurement technique for oral administration.*

FDA Label Image

Figure (Emc00 0002 15)

An instructional illustration showing a hand holding a tablet above a syringe. The illustration depicts the tablet being dropped into the syringe, with a downward arrow indicating the motion of the tablet moving into the syringe barrel. This visual likely demonstrates preparation steps for creating an oral suspension from a tablet form.*

FDA Label Image

Figure (Emc00 0002 16)

An instructional illustration showing a hand holding a syringe and twisting it in a circular motion, likely demonstrating how to prepare or mix medication before administration.*

FDA Label Image

Figure (Emc00 0002 17)

An instructional illustration showing hands preparing an oral syringe for use, including attaching a needle or tip and a directional arrow indicating assembly or movement.*

FDA Label Image

Figure (Emc00 0002 18)

An illustration showing a person administering oral medication with a syringe-like device into their mouth, likely demonstrating how to use a tablet for suspension formulation.*

FDA Label Image

Figure (Emc00 0002 19)

Illustration showing a person administering oral medication using a syringe. The image depicts the syringe being placed inside the mouth, indicating the method for giving the medication orally.*

FDA Label Image

Figure (Emc00 0002 20)

An instructional illustration showing how to measure 10 mL of liquid using a graduated measuring cup and a syringe or dropper, likely for preparing a suspension medication.*

FDA Label Image

Figure (Emc00 0002 21)

An instructional diagram showing a hand drawing liquid medication from a tube or vial into a syringe, demonstrating preparation of an oral suspension dose.*

FDA Label Image

Figure (Emc00 0002 22)

An instructional illustration showing a hand holding a syringe while removing a cap or tip from the syringe. A second hand is pulling or sliding the cap off in the direction indicated by an arrow, demonstrating how to prepare the syringe for use.*

FDA Label Image

Figure (Emc00 0002 23)

An illustration showing a medical feeding tube system with labeled 'Medication port' and 'Feeding port,' indicating separate entry points for medication and feeding. The image visually demonstrates how a syringe is connected to the medication port.*

FDA Label Image

Figure (Emc00 0002 24)

Illustration showing the use of a syringe to withdraw liquid medication from a container. The image emphasizes proper technique for oral suspension medication administration, depicting a hand pulling back the syringe plunger with an arrow indicating the direction.*

FDA Label Image

Figure (Emc00 0002 25)

An instructional illustration showing a hand pouring the contents of a 10 mL measuring syringe into a cup, with a close-up inset highlighting the 10 mL mark on the syringe. This image demonstrates measuring and transferring liquid, likely related to the preparation of an oral suspension.*

FDA Label Image

Figure (Emc00 0002 26)

An instructional black-and-white line drawing showing a hand holding a tablet and a bottle with a dropper. This illustration appears to depict preparing a suspension by dropping liquid from the dropper onto the tablet inside the bottle. It corresponds to the oral tablet for suspension dosage form.*

FDA Label Image

Figure (Emc00 0002 27)

EMCITATE (tiratricol) tablets for oral suspension, 350 mcg per tablet, packaged in a carton containing 60 tablets. The label states the tablets must be dispersed in water and not swallowed whole, chewed, or crushed. Manufactured for Rare Thyroid Therapeutics International AB and distributed by Egetis Therapeutics US Inc. The label includes storage instructions to keep refrigerated at 2°C to 8°C and protected from light.*

FDA Label Image

Figure (Emc00 0002 28)

Label for Emcitate (tiratricol) tablets for oral suspension, 350 mcg per tablet. Instructions indicate storage refrigerated at 2°C to 8°C (36°F to 46°F). Each label shows the Rare Thyroid Therapeutics as the labeler and includes a barcode, lot number placeholder, expiration date placeholder, and the NDC number 87216-0100-0. The label is repeated multiple times in a grid pattern with peel indicators.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.